1.Research on recombinant human PA2G4 family member Ebp1: current status and future perspective.
Chinese Journal of Oncology 2012;34(8):561-565
Adaptor Proteins, Signal Transducing
;
chemistry
;
metabolism
;
Animals
;
Apoptosis
;
Cell Differentiation
;
Cell Line, Tumor
;
Cell Proliferation
;
Humans
;
Neoplasms
;
pathology
;
Phosphorylation
;
Protein Isoforms
;
RNA-Binding Proteins
;
chemistry
;
metabolism
;
Transcription Factors
;
antagonists & inhibitors
4.Current status of surgical management of esophageal cancer in China and the future strategy.
You-Sheng MAO ; Jie HE ; Gui-Yu CHENG
Chinese Journal of Oncology 2010;32(6):401-404
China
;
Esophageal Neoplasms
;
pathology
;
surgery
;
Esophagectomy
;
methods
;
trends
;
Esophagoscopy
;
methods
;
Humans
;
Lymph Node Excision
;
methods
;
Survival Rate
5.HIGH LEVEL EXPRESSION AND ACTIVITY DETECTION OF SINGLE CHAIN IMMUNOTOXIN 183B_2ScFvPE38 AGAINST OVARIAN CARCINOMA
Fanglei YOU ; Jie FENG ; Yexia CHENG ; Tianyun FU ; Yu YAO ;
Acta Anatomica Sinica 1953;0(01):-
Objective To prepare the immunotoxin protein (183B 2ScFvPE38) which might be useful in immuno guided therapy for ovarian carcinoma and study the activity of the protein. Methods The methods of ELISA and cytotoxicity were used to study the immunotoxin after induced with IPTG and the activity of the immunotoxin. Results The expressed fusion proteins were detected mostly as inclusion bodies at high level, and soluble immunotoxins were also observed. The results showed liable activity of antibody part and toxic part. Conclusion The recombinant fusion protein 183B 2ScFvPE38 keeps the activity of both components and might be of great use in the future to deal with ovarian carcinoma. [
7.Automated synthesis and quality analysis of 18F-FMISO based on CFN-MPS-100 module
Liping CHEN ; Yu ZHANG ; Najing WU ; Xuyang YOU ; Liang CHENG ; Weixing WAN
Chinese Journal of Nuclear Medicine and Molecular Imaging 2015;35(4):303-305
Objective To synthesize 18F-FMISO and analyze the quality of the product.Methods 1-(2'-nitro-l'-imidazolyl)-2-O-tetrahydropyranyl-O-trluendulfonylpropanediol (NITIT) was taken as the precursor and simple one pot method was used.CFN-MPS-100 fluorine multifunction radiopharmaceutical chemical synthesis module was adopted to complete the radioactive fluorination reaction in a closed flat flask,and the crude product was purified by semi-preparative HPLC,the solvent was removed by rotary evaporation.Then 15 ml saline was added into the product to get 18F-FMISO injection.Radio-HPLC and radio-TLC were applied for quality control.Results 18F-FMISO was obtained in 60 min with the radiochemical yield of (32±5.0)% (no decay corrected,n=25).The radiochemical purity was above 99.0% and still above 98.5% after 6 h.The radioactive concentration was above 1.11 × 1012 Bq/L.The product was colorless solution,with pH value of 7.0.The radioactive nuclear purity was more than 99%.The K222 was less than 25 μg/ml.Conclusion 18 F-FMISO could be synthesized with automatic synthesis method based on the CFN-MPS-100 fluorine multifunction module.The labeling rate,stability and chemical purity are high.
8.Triple staining of immunohistochemistry.
You-zhi YU ; Min LIN ; Wei-cheng XUE ; Qiu-jing SONG ; Dan-hua SHEN
Chinese Journal of Pathology 2005;34(4):244-245
9.The Research Advance of Heterokaryon Incompatibility Mechanism in Fungi
Yuan-Cheng QI ; Lan-Qing WANG ; Li-You QIU ; Xiao-Qiang ZHANG ; Yu-Qian GAO ;
Microbiology 1992;0(02):-
Heterokaryon incompatibility is a widespread phenomenon among fungi,controlled by specific loci termed het (for heterokaryon incompatibility).This review focuses on recent developments in our understanding of the molecular mechanisms of nonself recognition and the relationship between the death progresses of heterokaryon incompatibility and associated proteins in fungi.The deep research of heterokaryon incompatibility mechanism will hopefully reveal underlying principles of the evolution of nonself recognition systems and will find some effective method for settling the instability of protoplast fusant of fungi.
10.Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas
Hui-Lin SHAO ; Dan-Hua SHEN ; Wei-Cheng XUE ; Yi LI ; You-Zhi YU ;
Chinese Journal of Obstetrics and Gynecology 2001;0(04):-
Objective To study the clinicopathologieal features and expression of cyclin D1 and p53 in epithelial ovarian tumors,and to investigate the correlation between pathogenesis of ovarian cancer and epithelial borderline tumors.Methods Fifty four cases of ovarian borderline tumors and 45 cases of ovarian carcinomas from the People's Hospital,Peking University were reviewed retrospectively.The clinical data and pathological findings were analyzed.Immunohistochemical study of cyclin D1 and p53 was performed in all 99 cases.Results(1)In borderline tumors,the age of patients ranged from 14-82 (mean age=42.5)years.International Federation of Gynecology and Obstetrics(FIGO)stage of borderline tumors was stage Ⅰ in 48 cases,stage Ⅱ in 3 cases,and stage Ⅲ in 3 cases.In ovarian carcinomas,the age of patients ranged from 26-80(mean age=53.5)years.FIGO stage of carcinoma was stage Ⅰ in 6 cases, stage Ⅱ in 8 cases,stage Ⅲ in 26 cases,and stage Ⅳ in 5 cases.In follow-up of 54 cases with borderline tumors the 5-year survival rate was 98% and of 45 cases with carcinomas a 5-year survival rate of 51% was noted.(2)In 54 cases of borderline tumors,mucinous types accounted for 56%(30/54)and serous types accounted for 30%(16/54).There were 5 cases with micropapillary pattern,3 cases with peritoneal implants,3 cases with lymph node involvement,6 cases with microinvasion,one case with intraepithelial carcinoma,and one case with mural nodules.In 45 cases of carcinomas,serous carcinoma was the most (49%,22/45).The remainder included 3 cases of mucinous types,8 cases of endometrioid types,6 cases of transitional cell types,3 cases of mixed phenotype and 3 cases of undifferentiated types.(3) Overexpression of cyclin D1 and p53 was observed in 31%(14/45)and 56%(25/45)of ovarian carcinomas, respectively.There was a significant association between p53 overexpression and tumor grade.In the borderline tumor group,69%(37/54)had overexpression of cyelin D1 and 6%(3/54)had overexpression of p53.There were significant differences in expression of cyclin D1 and p53 between conventional serous borderline tumors and high-grade serous carcinomas(cyclin D1:91% vs 26%;p53:0 vs 58%).However, micropapillary serous borderline tumors and low-grade serous carcinomas showed remarkably similar expression of cyelin D1 and p53.Conclusions Epithelial ovarian borderline tumors are distinct from ovarian cancer in clinical progress and prognosis,and histological types.Overexpression of cyclin D1 is common in ovarian borderline tumors and low grade carcinomas.And overexpression of p53 is more common in high grade ovarian carcinomas.Conventional serous borderline tumors are distinct from high-grade serous carcinomas in pathogenesis.Micropapillary serous borderline ovarian tumors may be closely related to low grade serous carcinomas.